Investigational Lilly drug (Phase 2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational Lilly drug (Phase 2), covering 2017-04-21 to 2017-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy [Phase 2]